The Glasgow Prognostic Score Determined During Concurrent Chemoradiotherapy Is an Independent Predictor of Survival for Cervical XXXX .

@entity5 @entity18880 @entity1 @entity1349
OBJECTIVE: The @entity18880 ( @entity18880 ) determined at pretreatment is important in the prediction of prognosis in @entity5 . We investigated if the @entity18880 used both at pretreatment and during concurrent chemoradiotherapy (CCRT) could predict the prognosis of @entity1 with @entity5 . METHODS: We collected @entity18880 and clinicopathological data from the medical records of 91 @entity1 who underwent CCRT for @entity5 ; their GPSs at pretreatment and during CCRT were retrospectively analyzed for correlations with recurrence and survival. Statistical analyses were performed using the Mann-Whitney U test. Disease-free survival (DFS) and @entity1349 ( @entity1349 ) were analyzed using the Kaplan-Meier method. Cox's proportional hazard regression was used for univariate and multivariate analyses. RESULTS: The median follow-up for all @entity1 who were alive at the time of last follow-up was 38.0 months (range, 1-108 months). The DFS and @entity1349 rates of @entity1 with a high @entity18880 during CCRT ( @entity18880 1 + 2; 55 @entity1 ; 60.4%) were significantly shorter than those for @entity1 with a low @entity18880 ( @entity18880 0; 36 @entity1 ; 39.6%) (DFS, P < 0.001; @entity1349 , P < 0.001). Furthermore, multivariate analyses showed that high @entity18880 during CCRT was an independent prognostic factor of survival for @entity1349 (P = 0.008). CONCLUSIONS: During CCRT, a high @entity18880 was revealed to be an important predictor of survival for @entity5 .
